A multicentered evaluation of ablation at higher power guided by ablation index: Establishing ablation targets for pulmonary vein isolation.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
03 2019
Historique:
received: 20 06 2018
revised: 15 11 2018
accepted: 13 12 2018
pubmed: 18 12 2018
medline: 6 5 2020
entrez: 18 12 2018
Statut: ppublish

Résumé

Pulmonary vein isolation (PVI) using high power delivered by SmartTouch Surround Flow (STSF) catheters guided by ablation index (AI) was evaluated in a multicenter registry. Patients with paroxysmal AF underwent PVI with STSF catheters using 30 W on the posterior wall and 40 W elsewhere. AI targets were 350 posterior walls and 450 elsewhere. Procedures were compared with controls using conventionally irrigated contact force-sensing catheters using conventional powers (25 W posterior wall and 30 W elsewhere) guided by force-time integral (no agreed targets). The waiting period of 30 minutes was observed before adenosine administration to assess acute pulmonary vein (PV) reconnection. One hundred patients from four centers were included: 50 patients in the high power ablation index (HPAI) group and 50 controls. Procedure time was 22% shorter in the HPAI group (156 [133.8-179] vs 199 [178.5-227] minutes; P < 0.001). Duration of the radiofrequency application was 37% shorter in the HPAI group (27.2 [21.5-35.8] vs 43.2 [35.1-52.1] minutes; P < 0.001). Acute PV reconnection was reduced (28 of 200 [14%] vs 48 of 200 [24%] veins; P = 0.015). Reconnection was predicted by a largest interlesion distance greater than 6 mm, a lesion with impedance drop less than 2.5 Ω, contact force less than 6 g, or less than 68% of the regional AI target (all P < 0.001). Freedom from atrial arrhythmia at 1 year off antiarrhythmic drugs after a single procedure was 78% in the HPAI group vs 64% in the control group ( P = 0.186). High-powered ablation guided by AI was safe and led to shorter procedure times with reduced acute PV reconnection compared with conventional ablation.

Sections du résumé

BACKGROUND
Pulmonary vein isolation (PVI) using high power delivered by SmartTouch Surround Flow (STSF) catheters guided by ablation index (AI) was evaluated in a multicenter registry.
METHODS
Patients with paroxysmal AF underwent PVI with STSF catheters using 30 W on the posterior wall and 40 W elsewhere. AI targets were 350 posterior walls and 450 elsewhere. Procedures were compared with controls using conventionally irrigated contact force-sensing catheters using conventional powers (25 W posterior wall and 30 W elsewhere) guided by force-time integral (no agreed targets). The waiting period of 30 minutes was observed before adenosine administration to assess acute pulmonary vein (PV) reconnection.
RESULTS
One hundred patients from four centers were included: 50 patients in the high power ablation index (HPAI) group and 50 controls. Procedure time was 22% shorter in the HPAI group (156 [133.8-179] vs 199 [178.5-227] minutes; P < 0.001). Duration of the radiofrequency application was 37% shorter in the HPAI group (27.2 [21.5-35.8] vs 43.2 [35.1-52.1] minutes; P < 0.001). Acute PV reconnection was reduced (28 of 200 [14%] vs 48 of 200 [24%] veins; P = 0.015). Reconnection was predicted by a largest interlesion distance greater than 6 mm, a lesion with impedance drop less than 2.5 Ω, contact force less than 6 g, or less than 68% of the regional AI target (all P < 0.001). Freedom from atrial arrhythmia at 1 year off antiarrhythmic drugs after a single procedure was 78% in the HPAI group vs 64% in the control group ( P = 0.186).
CONCLUSION
High-powered ablation guided by AI was safe and led to shorter procedure times with reduced acute PV reconnection compared with conventional ablation.

Identifiants

pubmed: 30556609
doi: 10.1111/jce.13813
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

357-365

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Gurpreet Dhillon (G)

Department of Cardiac Electrophysiology, Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.

Syed Ahsan (S)

Department of Cardiac Electrophysiology, Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.

Shohreh Honarbakhsh (S)

Department of Cardiac Electrophysiology, Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.

Wei Lim (W)

Department of Cardiac Electrophysiology, Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.

Marco Baca (M)

Department of Cardiac Electrophysiology, Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.

Adam Graham (A)

Department of Cardiac Electrophysiology, Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.

Neil Srinivasan (N)

Department of Cardiac Electrophysiology, Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.

Vinit Sawhney (V)

Department of Cardiac Electrophysiology, Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.

Simon Sporton (S)

Department of Cardiac Electrophysiology, Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.

Richard J Schilling (RJ)

Department of Cardiac Electrophysiology, Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.

Anthony Chow (A)

Department of Cardiac Electrophysiology, Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.

Matthew Ginks (M)

Department of Cardiology, Oxford Heart Centre, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Manav Sohal (M)

Department of Cardiology, St. Georges Hospital, London, UK.
Department of Cardiology, St Anthony's Hospital, Surrey, UK.

Mark M Gallagher (MM)

Department of Cardiology, St. Georges Hospital, London, UK.
Department of Cardiology, St Anthony's Hospital, Surrey, UK.

Ross J Hunter (RJ)

Department of Cardiac Electrophysiology, Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH